OQS
KRRO icon

Occudo Quantitative Strategies’s Korro Bio KRRO Stock Holding History

Occudo Quantitative Strategies’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,037
Closed -$110K – 1269
2022
Q1 		$110K Buy
1,037
+581
+127% +$111K 0.01% 1011
2021
Q4 		$117K Sell
456
-32
-7% -$9.73K 0.01% 942
2021
Q3 		$172K Sell
488
-93
-16% -$36.6K 0.02% 880
2021
Q2 		$289K Buy
+581
New +$284K 0.04% 610

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Occudo Quantitative Strategies's KRRO Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 1,037 shares — an estimated $110K sold.

Occudo Quantitative Strategies first reported a position in KRRO in Q2 2021 and held it in 4 quarters. The position peaked at $289K in Q2 2021. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,037 Korro Bio shares in Q2 2022, an estimated $110K.
  • Occudo Quantitative Strategies first reported a position in Korro Bio in Q2 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Korro Bio position peaked at $289K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.